Sandu Pharma Peer Comparison

BSE: 524703

₹36.48

₹0.64 (1.79%)

As on 30-Sep-2026 15:32IST

Market cap

₹36 Cr

Revenue (TTM)

₹70 Cr

P/E Ratio

20.1

P/B Ratio

Div. Yield

2.7 %

Edit

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Market cap (₹ Cr)	36	6,216	283	191	176
Revenue (₹ Cr)	70	851	201	136	90
Net Profit (₹ Cr)	1.77	236.31	17.10	-26.43	7.15
Net Margin (%)	2.53	27.06	8.42	-18.78	7.80
RoE (%)	4.12	57.63	28.72	-319.95	13.66
Price to Earnings	20.13	26.28	16.56	--	19.63
Price-To-Book	1.00	11.73	4.14	-9.47	2.82

Income Statement (₹ Cr)

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Operating Revenue	69.93	801.36	200.70	120.33	89.85
Total Income	70.38	809.86	203.12	122.53	91.70
Total Expenditure	66.93	450.89	176.00	125.33	76.22
EBITDA	3.00	350.47	24.69	-5.00	13.63
Depreciation	0.68	47.69	3.37	4.98	4.16
EBIT	2.32	302.78	21.32	-9.97	9.47
Interest	0.11	13.88	0.53	4.46	0.23
Other Income	0.44	8.50	2.42	2.19	1.86
Exceptional Items	--	--	--	--	-1.20
Profit before Tax	2.66	297.39	23.22	-12.24	9.90
Provision for Tax	0.89	75.70	6.11	1.72	2.74
Profit after Tax	1.77	221.70	17.10	-13.96	7.15

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Shareholder's Funds	43.67	467.08	67.60	9.49	62.54
Minority Interest	--	-0.13	0.00	3.40	0.00
Non-Current Liabilities	1.77	92.05	0.88	23.12	2.95
Current Liabilities	10.42	104.98	15.65	87.98	11.22
Total Liabilities	55.87	674.24	84.85	128.76	76.71

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Non-Current Assets	30.55	323.12	14.68	83.22	46.42
Current Assets	25.32	340.87	69.45	40.67	30.28
Total Assets	55.87	674.24	84.85	128.76	76.71
Total Debt*	0.00	0.45	2.42	65.97	1.46
Net Current Assets	14.90	235.88	53.80	-47.31	19.06
Contingent Liabilities	3.69	5.08	--	--	3.49

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Cash From Operating Activities	6.12	253.75	0.48	4.83	10.60
Cash Flow from Investing Activities	-0.57	-201.68	-8.55	-14.77	-10.08
Cash from Financing Activities	-0.94	-58.68	-0.77	-9.48	-0.54
Net Cash Inflow / Outflow	4.60	-6.61	-8.84	-19.42	-0.01

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
ROCE (%)	8.06	84.75	37.26	-8.94	16.70
ROE (%)	5.14	61.61	28.72	-86.43	13.66
ROA (%)	3.17	41.17	23.07	-10.55	9.78
EBIT Margin (%)	4.93	44.79	13.51	-2.33	17.23
Net Margin (%)	2.51	27.37	8.42	-11.39	7.80
Cash Profit Margin (%)	3.49	33.62	10.20	-7.15	12.59

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Revenue Growth (%)	4.08	70.84	23.19	11.57	-9.55
EBIT Growth (%)	17.58	143.64	80.87	-138.57	147.29
Net Profit Growth (%)	14.03	177.32	74.24	-1,517.68	259.44
EPS Growth (%)	14.03	177.51	74.24	-840.72	260.17
Book Value Growth (%)	5.37	81.73	31.25	-88.76	48.29

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Price / Earnings	16.69	30.25	13.83	0.00	13.81
Price / Book Value	0.84	14.46	3.50	129.43	1.58
Dividend Yield (%)	3.28	0.83	0.47	0.00	0.00
EV/EBITDA	6.57	18.39	8.01	-173.00	6.31
Market Cap (₹ Cr)	29.48	6,711.02	236.56	422.59	98.58

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Debt to Equity	0.00	0.00	0.04	20.21	0.02
Short term debt to equity ratio	--	0.00	0.01	4.86	0.02
Current Ratio	2.43	3.25	4.44	0.46	2.70
Quick Ratio	1.42	3.05	3.77	0.32	2.36
Interest Coverage	24.71	22.42	45.12	-1.75	44.76

	Sandu Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Debtors to sales (%)	7.74	8.73	7.21	16.04	8.39
Asset Turnover	1.25	1.49	2.71	0.95	1.23
Receivable days	26.53	35.27	18.59	51.00	27.60
Inventory Days	64.25	7.23	13.67	41.35	15.99
Payable days	51.77	77.55	201.66	128.93	152.09
Cash Conversion Cycle	39.02	-35.04	-169.40	-36.58	-108.51

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.